Capitalizing on Chemogenomic Concepts: Preclinical Safety Analysis to Help Develop Drugs, Not Duds

ISSN： 1176-3469

Source： Pharmaceutical & Diagnostic Innovation, Vol.3, Iss.5, 2005-01, pp. : 3-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preclinical Drug Safety Analysis by Chemogenomic Profiling in the Liver

By Fielden Mark R. Pearson Cecelia Brennan Richard Kolaja Kyle L.

American Journal of PharmacoGenomics, Vol. 5, Iss. 3, 2005-01 ,pp. : 161-171

Adis International

Access to resources Recommend Favorite

Preclinical Cardiac Safety Assessment of Drugs

By Hanton Gilles

Drugs in R&D, Vol. 8, Iss. 4, 2007-01 ,pp. : 213-228

Adis International

Access to resources Recommend Favorite

Thematic Analysis™ : A Chemogenomic Approach to GPCR Drug Discovery

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 15, 2011-08 ,pp. : 1925-1943

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical Investigation of the Safety of Eplir

By Saratikov A. Livshits N. Burchenkova F. Kadychagova N. Novozheeva T. Akhmedzhanov R. Perevozchikova T. Bashirova L.

Pharmaceutical Chemistry Journal, Vol. 39, Iss. 2, 2005-02 ,pp. : 64-66

Springer Publishing Company

Access to resources Recommend Favorite

Biologics Safety Preclinical, Clinical and Regulatory

By Hennig Renald

Expert Opinion on Drug Safety, Vol. 2, Iss. 6, 2003-11 ,pp. : 609-611

Informa Healthcare

Access to resources Recommend Favorite